Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
injectable use carries added risks of injection-site irritation, and systemic use should be avoided during pregnancy since copper crosses the placenta and no controlled human pregnancy data exists
Most BPC-157 preclinical work uses dosages around 10 mcg/kg administered intraperitoneally or subcutaneously in rodents, with study durations ranging from single administration to 14-day periods
The 3.0 mg step was never studied
doi: 10.18632/aging.102682
US$ 23.55
US$ 21.55
US$ 29.45
US$ 26.73
US$ 20.61
